Efficacy and Safety of Seladelpar vs. Elafibranor in Patients with Primary Biliary Cholangitis: A Matching-Adjusted Indirect Comparison (MAIC)

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Efficacy and Safety of Seladelpar vs. Elafibranor in Patients with Primary Biliary Cholangitis: A Matching-Adjusted Indirect Comparison (MAIC)

	AASLD 2025 Nov 7-11 Wash DC David Jones1